Doxorubicin Market Scope And Analysis

  • Report Code : TIPRE00011780
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

Doxorubicin Market Size and Scope by 2031

Buy Now


Doxorubicin Market Report Scope

Report Attribute Details
Market size in 2023 US$ 1.47 Billion
Market Size by 2031 US$ 2.35 Billion
Global CAGR (2023 - 2031) 6.1%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Drug Formulation
  • Lyophilized Powder
  • Doxorubicin Injection
By Application
  • Breast Cancer
  • Kidney Cancer
  • Liver Cancer
  • Sarcoma
  • Ovarian Cancer
  • Lung Cancer
  • Leukemia
  • Multiple Myeloma
By Distribution Channel
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Accord Healthcare
  • Cipla Inc
  • Dr Reddy s Laboratories
  • Meiji Holdings Co Ltd
  • Janssen Pharmaceuticals Johnson and Johnson Services Inc
  • Novartis AG
  • Pfizer Inc
  • Sun Pharmaceutical Industries Ltd
  • Baxter International Inc
  • Zydus Cadila